Guardant Health (GH) News Today → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free GH Stock Alerts $27.10 -0.37 (-1.35%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 31 at 8:05 AM | businesswire.comGuardant Health Named to TIME100 Most Influential CompaniesMay 31 at 1:40 AM | americanbankingnews.comGuardant Health, Inc. (NASDAQ:GH) Forecasted to Post FY2024 Earnings of ($3.57) Per ShareMay 30 at 8:05 AM | businesswire.comGuardant Health to Present Studies at 2024 ASCO Annual Meeting Highlighting Contributions of Its Blood Tests and Real-World Data to Advancing Precision Oncology and Cancer ScreeningMay 30 at 6:00 AM | marketbeat.comFY2024 EPS Estimates for Guardant Health, Inc. Reduced by Leerink Partnrs (NASDAQ:GH)Guardant Health, Inc. (NASDAQ:GH - Free Report) - Equities researchers at Leerink Partnrs decreased their FY2024 EPS estimates for Guardant Health in a research report issued to clients and investors on Tuesday, May 28th. Leerink Partnrs analyst P. Souda now anticipates that the company will postMay 30 at 1:56 AM | americanbankingnews.comGuardant Health, Inc. (NASDAQ:GH) Given Consensus Rating of "Moderate Buy" by BrokeragesMay 27, 2024 | marketbeat.comEaton Financial Holdings Company LLC Buys New Position in Guardant Health, Inc. (NASDAQ:GH)Eaton Financial Holdings Company LLC purchased a new stake in Guardant Health, Inc. (NASDAQ:GH - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 80,707 shares of the company's stock, valued at approximately $2May 26, 2024 | americanbankingnews.comGuardant Health (NASDAQ:GH) Earns Overweight Rating from StephensMay 25, 2024 | bizjournals.comPeninsula cancer test maker lands key nod from FDA panel, a step toward a big paydayMay 24, 2024 | markets.businessinsider.comEvaluating Guardant Health: Insights From 5 Financial AnalystsMay 24, 2024 | marketbeat.comGuardant Health (NASDAQ:GH) Earns "Overweight" Rating from StephensStephens restated an "overweight" rating and issued a $44.00 target price on shares of Guardant Health in a research note on Friday.May 24, 2024 | za.investing.comExact Sciences stock drops as Guardant Health test supported by FDA panelMay 24, 2024 | msn.comFDA Advisory Panel Supports Approval Of Guardant Health's Blood Test For Colorectal Cancer ScreeningMay 24, 2024 | msn.comGuardant jumps as trading resumes after FDA AdCom vote on cancer testMay 24, 2024 | finance.yahoo.comGuardant Health Jumps — As Exact Sciences Slumps — On A Key FDA Move For Blood TestsMay 24, 2024 | marketbeat.comGuardant Health (NASDAQ:GH) Shares Gap Up to $22.51Guardant Health (NASDAQ:GH) Shares Gap Up to $22.51May 24, 2024 | investors.comGuardant Health Rockets After FDA Panel Recommends Approval For Blood-Based Colon Cancer TestMay 24, 2024 | markets.businessinsider.comBuy Rating Affirmed for Guardant Health Amid Positive FDA Outlook and Market OpportunityMay 23, 2024 | businesswire.comFDA Advisory Committee Panel Strongly Recommends Approval of Shield™ Blood Test for Colorectal Cancer Screening as a Primary Non-Invasive Screening OptionMay 23, 2024 | reuters.comU.S. FDA advisers back approval for Guardant's blood-based cancer testMay 23, 2024 | finance.yahoo.comNatera to Present at the 2024 Leerink Partners Healthcare Crossroads ConferenceMay 23, 2024 | marketbeat.comGuardant Health (NASDAQ:GH) Trading 2.8% Higher Guardant Health (NASDAQ:GH) Shares Up 2.8%May 23, 2024 | markets.businessinsider.comGuardant Health Trading Suspended On Nasdaq Pending ShieldTM's Premarket Approval MeetingMay 23, 2024 | msn.comGuardant shares on hold for trading ahead of AdCom meeting on cancer testMay 23, 2024 | marketbeat.comClearbridge Investments LLC Sells 358,196 Shares of Guardant Health, Inc. (NASDAQ:GH)Clearbridge Investments LLC lowered its stake in Guardant Health, Inc. (NASDAQ:GH - Free Report) by 19.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,466,362 shares of the company's stock after selling 358,May 23, 2024 | businesswire.comGuardant Health Stock Trading Temporarily Halted; FDA Panel to Assess Premarket Approval Application for Shield Blood Test for Colorectal Cancer ScreeningMay 22, 2024 | businesswire.comGuardant Health to Participate in Upcoming Investor ConferencesMay 22, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: TELA Bio (TELA), Rezolute (RZLT)May 21, 2024 | reuters.comUS FDA staff says Guardant's cancer test may fail to detect some tumorsMay 21, 2024 | msn.comGuardant Health slips as FDA comments on cancer screening testMay 21, 2024 | businesswire.comTrinity Industries, Inc. Announces Offering of Additional 7.750% Senior Notes Due 2028May 21, 2024 | businesswire.comGuardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic IndicationsMay 17, 2024 | marketbeat.comGuardant Health, Inc. (NASDAQ:GH) Short Interest UpdateGuardant Health, Inc. (NASDAQ:GH - Get Free Report) saw a large increase in short interest during the month of April. As of April 30th, there was short interest totalling 10,160,000 shares, an increase of 6.3% from the April 15th total of 9,560,000 shares. Based on an average daily trading volume, of 1,920,000 shares, the days-to-cover ratio is presently 5.3 days.May 17, 2024 | businesswire.comGuardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 16, 2024 | marketbeat.comGuardant Health (NASDAQ:GH) Trading 4.7% Higher Guardant Health (NASDAQ:GH) Stock Price Up 4.7%May 16, 2024 | businesswire.comGuardant Health to present real-world data supporting performance of Shield™ blood test for colorectal cancer screening at 2024 Digestive Disease WeekMay 14, 2024 | markets.businessinsider.comBuy Rating Affirmed for Guardant Health Amid Strong Q1 Performance and Positive Revenue OutlookMay 13, 2024 | benzinga.comMarket Whales and Their Recent Bets on Guardant Health OptionsMay 13, 2024 | markets.businessinsider.comGuardant Health Receives ‘Buy’ Rating on Strong Q1 Performance and Positive Financial OutlookMay 13, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Guardant Health (GH), Argenx Se (ARGX) and Annexon Biosciences (ANNX)May 13, 2024 | finance.yahoo.comGuardant Health, Inc. (NASDAQ:GH) Q1 2024 Earnings Call TranscriptMay 11, 2024 | finance.yahoo.comGuardant Health First Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsMay 11, 2024 | finance.yahoo.comGuardant Health, Inc. (NASDAQ:GH) Shares Could Be 44% Below Their Intrinsic Value EstimateMay 10, 2024 | benzinga.comGuardant Health Options Trading: A Deep Dive into Market SentimentMay 9, 2024 | businesswire.comGuardant Health Reports First Quarter 2024 Financial Results and Increases 2024 Revenue GuidanceMay 7, 2024 | businesswire.comGuardant Health to Participate in Upcoming Investor ConferencesMay 7, 2024 | finance.yahoo.comGuardant Health Surpasses 500 Peer-Reviewed Publications MilestoneMay 2, 2024 | wsj.comGuardant Health Inc.May 1, 2024 | msn.comNew World Bank Report Calls for Strengthening Resilience of Ghana's Health System in Response to Climate Change [press release]April 30, 2024 | marketbeat.com142,745 Shares in Guardant Health, Inc. (NASDAQ:GH) Bought by Beck Bode LLCBeck Bode LLC bought a new position in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 142,745 shares of the company's stock, valued at approximately $3,861,00April 30, 2024 | msn.comGH Spoilers Weekly Preview Video: Valentin and Brennan Plan to Kill Two Birds with One Stone Get Guardant Health News Delivered to You Automatically Sign up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now GH Media Mentions By Week GH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GH News Sentiment▼0.010.76▲Average Medical News Sentiment GH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GH Articles This Week▼124▲GH Articles Average Week Get Guardant Health News Delivered to You Automatically Sign up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Genetron News Exact Sciences News RadNet News Fortrea News Veracyte News CareDx News Viridian Therapeutics News Castle Biosciences News Fulgent Genetics News Celcuity News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GH) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressBill Clinton Backing Biden Replacement???The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardant Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
